newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals to Present at the Cowen 43rd Annual Health Care Conference

DEVON, Pa., March 01, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders,